The human EZH2 gene: genomic organisation and revised mapping in 7q35 within the critical region for malignant myeloid disorders.
about
Functional characterization of EZH2β reveals the increased complexity of EZH2 isoforms involved in the regulation of mammalian gene expressionLong non-coding RNA SOX2OT: expression signature, splicing patterns, and emerging roles in pluripotency and tumorigenesisDiverse involvement of EZH2 in cancer epigeneticsAberrant upregulation of 14-3-3σ and EZH2 expression serves as an inferior prognostic biomarker for hepatocellular carcinomaRemarkable compartmentalization of transposable elements and pseudogenes in the heterochromatin of the Tetraodon nigroviridis genome.Identification of two critically deleted regions within chromosome segment 7q35-q36 in EVI1 deregulated myeloid leukemia cell linesEZH2: not EZHY (easy) to deal.Role of EZH2 polymorphisms in esophageal squamous cell carcinoma risk in Han Chinese population.The prognostic role of EZH2 expression in rectal cancer patients treated with neoadjuvant chemoradiotherapyEZH2 is downstream of the pRB-E2F pathway, essential for proliferation and amplified in cancerNotch1 intracellular domain increases cytoplasmic EZH2 levels during early megakaryopoiesis.EZH2: novel therapeutic target for human cancerEffects of EZH2 polymorphisms on susceptibility to and pathological development of hepatocellular carcinoma.Impact of EZH2 polymorphisms on urothelial cell carcinoma susceptibility and clinicopathologic featuresA polymorphism in the promoter is associated with EZH2 expression but not with outcome in advanced pancreatic cancer patients.MicroRNA-1297 regulates hepatocellular carcinoma cell proliferation and apoptosis by targeting EZH2.MicroRNA-506 suppresses tumor proliferation and metastasis in colon cancer by directly targeting the oncogene EZH2Multifaceted role of EZH2 in breast and prostate tumorigenesis: epigenetics and beyond.Epigenetic modification in gliomas: role of the histone methyltransferase EZH2.Novel perspectives of long non-coding RNAs in esophageal carcinoma.Aberrant overexpression of EZH2 and H3K27me3 serves as poor prognostic biomarker for esophageal squamous cell carcinoma patients.Inhibition of EZH2 reverses chemotherapeutic drug TMZ chemosensitivity in glioblastoma.Regulation of pancreatic tumor cell proliferation and chemoresistance by the histone methyltransferase enhancer of zeste homologue 2.Effects of Emdogain on osteoblast gene expression.The Polycomb group protein EZH2 is upregulated in proliferating, cultured human mantle cell lymphoma.Association between EZH2 polymorphisms and colorectal cancer risk in Han Chinese population.High expression of EZH2 is associated with tumor aggressiveness and poor prognosis in patients with esophageal squamous cell carcinoma treated with definitive chemoradiotherapy
P2860
Q21198854-9173260B-7D66-4E14-84A6-F8F898535CE2Q28082535-52AE3E68-043E-4EA5-8FA2-111D6AB22555Q28084911-B3B7C9F9-3453-46DD-A387-EFDBC04E9C1BQ28248070-17ECA988-D140-4C68-B7B8-FBBFFAC6FA00Q30860364-2FC713B8-7855-4D51-8981-26FD36B5A98CQ33525049-87EE0BDF-F356-4D89-AC9C-9826799CA874Q33610902-DB7C9A52-03D8-4A25-AF9E-1EA3384A3428Q34072487-0B3F9AC2-B249-41F1-B8D8-3C2D8D8453D8Q34175876-01A68C6B-0912-4581-B130-765299CE125AQ34268216-35BBF45A-AEA1-4850-B295-992435738D1AQ34390123-BC045C3B-C2D7-427F-832B-0B4DF74B6B90Q34691625-115A43AF-95CC-4C38-B385-ACAE864A58DEQ34990394-76121C87-48AB-438A-B995-9BA8744484B7Q35137483-EEFC56DE-8774-4E2D-AEF9-A3FB84FBF5D8Q35163440-8F279C51-922D-4C32-9E36-9A7505FABC6BQ35854018-CFE94722-2B4E-4D8F-9358-793ED74DC5F1Q36544911-239A98A9-6D22-48F1-A383-32511ADEFFB2Q37089496-77F0FE0B-12AA-4533-AFAC-719EE30E11CAQ38232172-DCA0FC6C-4CB2-4CE8-AA2E-9D72BF28B4EFQ38590748-F4D446A5-8C35-4E2F-AC35-0ACDE74239ACQ38814812-E7D045CF-4E21-482B-AFAF-54FB73FB5396Q38940136-BC9A1E05-BA26-4DCE-8E25-26C2D12E0BADQ39921991-A6A037F4-568B-41A8-8A15-58C4FDBA06EDQ40279851-3A67BB61-8AA0-4685-B2F3-410FE57A80A7Q40813288-A6AD82B0-8123-4F3E-A20B-474706EEE78BQ54224805-3B1AD4FB-F344-4757-B7EE-0A6CFD885CE4Q58321557-1B96EB9B-F8B4-412E-822C-D98EE7DF9769
P2860
The human EZH2 gene: genomic organisation and revised mapping in 7q35 within the critical region for malignant myeloid disorders.
description
2000 nî lūn-bûn
@nan
2000 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի մարտին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
The human EZH2 gene: genomic o ...... r malignant myeloid disorders.
@ast
The human EZH2 gene: genomic o ...... r malignant myeloid disorders.
@en
type
label
The human EZH2 gene: genomic o ...... r malignant myeloid disorders.
@ast
The human EZH2 gene: genomic o ...... r malignant myeloid disorders.
@en
prefLabel
The human EZH2 gene: genomic o ...... r malignant myeloid disorders.
@ast
The human EZH2 gene: genomic o ...... r malignant myeloid disorders.
@en
P2093
P356
P1476
The human EZH2 gene: genomic o ...... or malignant myeloid disorders
@en
P2093
P2888
P304
P356
10.1038/SJ.EJHG.5200439
P577
2000-03-01T00:00:00Z